Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 883 results for "for merck"

Merck Serono as Pioneer in Assisted Reproductive Treatments Takes Leading Role in Fertility Technologies Signing a Global Collaboration Agreement with Genea Biomedx
PR Newswire

Merck partners with Aussie fertility technology firm

Singapore: Merck, a leading company for innovative and top-quality high-tech products in healthcare, lifescience and performance materials, has collaborated with Australia based fertility technology firm, Genea Biomedx. With this partnership, ... Bio Spectrum Asia, 40 minutes ago

295 images for for merck

CIO East Africa, 3 days ago
CIO East Africa, 2 days ago
PR Newswire, 5 hours ago
HIT Consultant, 3 days ago
One News Page United Kingdom, 3 days ago
Capital Bay, 3 days ago
Capital Bay, 3 days ago
Business Today India, 1 week ago
One News Page United Kingdom, 6 days ago
Korea Herald, 5 hours ago

Merck and NanoString to collaborate on predictive test for Keytruda

News Editor Merck (MRK +0.3%) and NanoString Technologies (NSTG +1.4%) establish a clinical research collaboration to develop an assay that will optimize immune-related gene expression signatures and evaluate the potential to predict patient ...
 Seeking Alpha22 hours ago Merck, NanoString Collaborate To Develop Immune-Related Gene Expression Assay  RTTNews.com23 hours ago Merck and NanoString Announce Clinical Research Collaboration to Develop an Immune-Related Gene Expression Assay for Use in the Development Program for KEYTRUDA® (pembrolizumab)  Business Wire1 day ago Agreements/contracts: Merck, NanoString to use nCounter for gene expression  Medical Device Daily2 hours ago

Merck Submits NDA To FDA For Grazoprevir/Elbasvi

Merck & Co. Inc. (MRK) announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) for grazoprevir/elbasvir (100mg/50mg), an investigational once-daily, single tablet combination therapy for the treatment of ...
 RTTNews.com11 hours ago Merck files NDA for combo HCV regimen  Seeking Alpha15 hours ago Merck Submits NDA for Hepatits C Drug Grazoprevir/Elbasvir  PharmaAsia6 hours ago Merck's Keytruda shrinks lung cancer tumors, FDA approval sought  Reuters1 month ago
Korea Herald

Merck opening an OLED center

Merck, a leading chemical and pharmaceutical company, opened a research institute for the application of organic light-emitting diode (OLED) materials Thursday in Pyeongtaek, Gyeonggi. With an investment of 10 billion won ($9 million), the OLED ...
 Korea Joongang Daily20 hours ago Merck invests 7m euros to open OLED Application Center  EE Times Europe20 hours ago Merck Korea launches OLED Application Center  Korea Herald1 day ago MERCK KGAA : Inaugurates OLED Application Center (OAC) in Korea  4 Traders1 day ago

Genea seals deal with Merck on IVF product

IVF group Genea, which has a 15 per cent share of the Australian market, has signed an agreement with global pharmaceutical company Merck to export its fertility technology internationally. The global fertility market is presently valued at $A3.4 ...
 Individual.com14 hours ago Genea seals IVF deal with Merck  WA Today22 hours ago MERCK KGAA : Serono Enters into Co-Development Agreement with Genea Biomedx  4 Traders2 hours ago

Potential Merck (MRK) Trade Has 5.72% Downside Protection

A covered call identified by's patented algorithms on Merck & Co Inc. ("MRK) could yield about 2.57% (6.65% annualized, for comparison purposes only) in 141 days. Pair a ...
 Individual.com17 hours ago Merck (MRK) Trading Near $60.33 Resistance Level  PredictWallStreet2 days ago Merck (MRK) Trading Near $59.68 Resistance Level  Individual.com1 day ago Merck (MRK) Trading Near $61.44 Resistance Level  Individual.com1 week ago

Merck & Co., Inc. Extends Reach Into Immunotherapy Drugs Market; Joins Hands With NanoString Technologies

Merck & Co., Inc. ( NYSE:MRK ) announced on Thursday it is entering into a clinical research collaboration with NanoString Technologies Inc ( NASDAQ:NSTG ), to develop a particular test to help enhance benefits from the company's potential ...
 Bidness Etc15 hours ago Merck and Co., Inc. Extends Reach Into Immunotherapy Drugs Market; Joins Hands With NanoString Technologies  Mr Top Step13 hours ago

How The Big Money Cashes In On Merck

1:44 PM ET | About: Merck & Co Inc. (MRK), Includes: ABBV, AZN, BMY, GILD, PFE, RHHBY by: Pharma Doc Summary Merck's catalyst is ASCO and its star poster child is Keytruda. Merck will show off Keytruda in 5 different cancer subtypes this ...
 Seeking Alpha18 hours ago

Merck reports lower Q1 net income, provides annual outlook

Merck KGaA has reported that net income attributable to the shareholders for the first quarter of 2015 was E281.7 million, or E0.65 per share, compared to E325.2 million, or E0.75 per share, for the same quarter of 2014. For 2015, the company ...
 Individual.com22 hours ago Merck KGaA Q1 Net Profit Down  Crawford Financial Planning1 week ago

New drugs from Bristol, Merck at forefront of annual meeting of the American Society of Clinical Oncology

Results from clinical trials will be presented starting Friday in Chicago at the annual meeting of the American Society of Clinical Oncology. New data to be released this weekend should help deepen the understanding of how broadly new drugs that unleash the ...
 Economic Times1 day ago Merck & ASCO: It Is All About Keytruda (Pembrolizumab)  Trefis1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less